Anthropic pushes funding, IPO and AI rollout as ethical model faces market test

Anthropic pushes funding, IPO and AI rollout as ethical model faces market test
Anthropic’s ethical AI test

Anthropic is moving into a decisive new phase as the AI company combines explosive growth with a widening dispute over how far its systems should be used by governments and critical industries. The tension is sharpening just as the group prepares a broad launch of its new Mythos model, pursues a public listing and defends its restrictions on military and surveillance applications.

Highlights

  • Anthropic secures $65bn funding round, reaches $900bn valuation, and files for an IPO expected to surpass $1tn, outpacing OpenAI.
  • Anthropic plans Mythos rollout to 150 critical infrastructure companies in 15 countries, serving over 100 million people, amid legal dispute with the U.S. Department of Defense.
  • Internal tensions rise as ethical commitments face strain under rapid commercial growth, highlighted by ongoing litigation over Pentagon's supply chain risk designation.

Growth strategy, legal fight and product expansion

As reported by Financial Times, Anthropic has moved ahead of OpenAI in valuation after announcing a new $65bn funding round that lifts the company to $900bn, and it has also filed paperwork for an initial public offering expected to exceed $1tn. The company is simultaneously preparing to roll out Mythos, a model described by experts as a powerful cyber tool, to 150 companies in 15 countries that manage critical infrastructure affecting more than 100 million people.

The expansion comes after a confrontation with the U.S. Department of Defense over the terms under which Claude could be used. Anthropic sought to block two categories, mass surveillance of Americans and lethal autonomous warfare, after the Pentagon asked for access for all lawful purposes.

That dispute escalates in March, when Anthropic sues the Pentagon over a designation that labels it a supply chain risk to national security. The company argues in court that the move threatens severe business harm and reflects retaliation for its criticism of the administration.

Ethical governance under commercial pressure

Anthropic was founded as a public benefit corporation with a stated aim of balancing profit with positive social impact, and that structure is now facing a major test as the company scales. Its founders left OpenAI promising to build advanced systems that are safer and more responsible, but rapid commercial success is increasing pressure on that mission.

The internal strain becomes visible after the dispute with Washington intensifies. Dario Amodei tells employees in a Slack message that Anthropic is being punished for holding to its red lines on safety and regulation, while accusing OpenAI and the Trump administration of misrepresenting the disagreement.

The broader question for the AI sector is whether a company can impose costly limits on its own technology and still dominate a market moving at extreme speed. Anthropic is effectively testing whether superior products and transparent safeguards can drive what its leaders describe as a race to the top, even as its scale raises fresh concerns over governance, military use and systemic risk.

In our earlier article on printed circuit boards (PCBs) as an AI and defense supply-chain weak point, we explained how heavy reliance on China-made PCBs for major AI hardware has intensified U.S. security concerns and driven calls for more domestic sourcing. We also noted that surging demand is boosting U.S. manufacturers even as costs rise, while policymakers weigh subsidies and requirements aimed at hardening procurement for military and critical-use systems.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.